193 related articles for article (PubMed ID: 7722490)
1. Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens.
Brun P; Steinberg R; Le Fur G; Soubrié P
J Neurochem; 1995 May; 64(5):2073-9. PubMed ID: 7722490
[TBL] [Abstract][Full Text] [Related]
2. Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
Brun P; Leonetti M; Sotty F; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
J Neurochem; 2001 Jun; 77(6):1542-52. PubMed ID: 11413237
[TBL] [Abstract][Full Text] [Related]
3. SR 48692-sensitive neurotensin receptors modulate acetylcholine release in the rat striatum.
Steinberg R; Rodier D; Mons G; Gully D; Le Fur G; Soubrié P
Neuropeptides; 1995 Jul; 29(1):27-31. PubMed ID: 7566510
[TBL] [Abstract][Full Text] [Related]
4. SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission.
Steinberg R; Brun P; Fournier M; Souilhac J; Rodier D; Mons G; Terranova JP; Le Fur G; Soubrié P
Neuroscience; 1994 Apr; 59(4):921-9. PubMed ID: 8058127
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic antagonists attenuate neurotensin-stimulated accumbens and striatal dopamine metabolism.
Rivest R; Marsden CA
Neuroscience; 1992; 47(2):341-9. PubMed ID: 1641127
[TBL] [Abstract][Full Text] [Related]
6. The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat.
Fadel J; Dobner PR; Deutch AY
Neurosci Lett; 2001 Apr; 303(1):17-20. PubMed ID: 11297813
[TBL] [Abstract][Full Text] [Related]
7. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
[TBL] [Abstract][Full Text] [Related]
8. SR 48692 inhibits neurotensin-induced [3H]dopamine release in rat striatal slices and mesencephalic cultures.
Brouard A; Heaulme M; Leyris R; Pelaprat D; Gully D; Kitabgi P; Le Fur G; Rostene W
Eur J Pharmacol; 1994 Mar; 253(3):289-91. PubMed ID: 8200423
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of dopamine antagonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats.
Yamada S; Takaki T; Yokoo H; Tanaka M
J Pharm Pharmacol; 1995 Mar; 47(3):259-62. PubMed ID: 7602493
[TBL] [Abstract][Full Text] [Related]
10. Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade.
Santucci V; Gueudet C; Steinberg R; Le Fur G; Soubrié P
Synapse; 1997 Aug; 26(4):370-80. PubMed ID: 9215596
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo.
Rivest R; Jolicoeur FB; Marsden CA
Neuropharmacology; 1991 Jan; 30(1):25-33. PubMed ID: 2046877
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain.
Merchant KM; Bush LG; Gibb JW; Hanson GR
Brain Res; 1989 Oct; 500(1-2):21-9. PubMed ID: 2532557
[TBL] [Abstract][Full Text] [Related]
13. Involvement of potentially distinct neurotensin receptors in neurotensin-induced stimulation of striatal [3H]dopamine release evoked by KCl versus electrical depolarization.
Heaulme M; Leyris R; Le Fur G; Soubrie P
Neuropharmacology; 1997 Oct; 36(10):1447-54. PubMed ID: 9423933
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
[TBL] [Abstract][Full Text] [Related]
15. Repeated administration of the neurotensin receptor antagonist SR 48692 differentially regulates mesocortical and mesolimbic dopaminergic systems.
Azzi M; Betancur C; Sillaber I; Spanagel R; Rostène W; Bérod A
J Neurochem; 1998 Sep; 71(3):1158-67. PubMed ID: 9721741
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
Compton DR; Johnson KM
J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological evidence that neurotensin mediates prolactin-induced activation of tuberoinfundibular dopamine neurons.
Hentschel K; Cheung S; Moore KE; Lookingland KJ
Neuroendocrinology; 1998 Aug; 68(2):71-6. PubMed ID: 9705573
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological evidence for common mechanisms underlying the effects of neurotensin and neuroleptics on in vivo dopamine efflux in the rat nucleus accumbens.
Blaha CD; Phillips AG
Neuroscience; 1992 Aug; 49(4):867-77. PubMed ID: 1436486
[TBL] [Abstract][Full Text] [Related]
19. Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study.
Wu Q; Reith ME; Walker QD; Kuhn CM; Carroll FI; Garris PA
J Neurosci; 2002 Jul; 22(14):6272-81. PubMed ID: 12122086
[TBL] [Abstract][Full Text] [Related]
20. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
